ArticleScientific reports2024

Comparison of diagnostic performance between Oncomine Dx target test and AmoyDx panel for detecting actionable mutations in lung cancer.

Yuki Nagakubo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.